Latest News and Press Releases

Following the compulsory acquisition of the remaining shares in Weifa ASA that was effected on 12 October 2017, an extraordinary general meeting was held on 17 October 2017 in Weifa ASA. Please ...

The quarterly report for Q3 2017 will be published on 30 November 2017, and not on 26 October 2017 as stated in the announcement of 9 December 2016. For further information, please contact: ...

Karo Pharma AB ("Karo Pharma") has today successfully completed the voluntary offer for Weifa ASA ("Weifa"). Payment of the offer price is being made today to the Weifa shareholders who accepted the...

Following final registration of acceptances, the final acceptance level in Karo Pharma AB's ("Karo Pharma") voluntary offer ("Voluntary Offer") to acquire all shares in Weifa ASA ("Weifa") is...

On expiration of the offer period on 3 October, 2017 at 16:30 CEST, Karo Pharma AB ("Karo Pharma") had received acceptances for the voluntary offer ("Voluntary Offer") to acquire all shares in Weifa...

Reference is made to the offer document dated 11 September 2017 regarding Karo Pharma AB's ("Karo Pharma") conditional voluntary offer (the "Voluntary Offer") to acquire all of the shares in Weifa...

Weifa ASA ("Weifa"; OSE: WEIFA) today announced that Karo Pharma AB (publ) ("Karo Pharma"), has commenced the voluntary cash offer (the "Offer") to acquire the entire issued share capital of Weifa for...

Weifa ASA - mandatory notification of trade and disclosure of shareholding Reference is made to the announcement from Karo Pharma ("Karo Pharma") and Weifa ASA ("Weifa") today regarding the...

Karo Pharma AB announces a recommended voluntary cash offer to acquire all shares in Weifa ASA             · Cash offer at NOK 35 per Weifa share valuing the total share capital of Weifa at...

Oslo, 13 July 2017 Record second-quarter revenues of NOK 98.6 million (NOK 95.3 million) All-organic growth of 3.4% Second-quarter adjusted EBITDA of NOK 22.1 million (NOK 18.6 million) ...